Gwynneth S. Ballentine

Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland.

Rapid Pathogen Screening, Inc. is an emerging biotechnology company strategically focused on designing, developing, and delivering novel point-of-care tests for infectious diseases and inflammatory conditions as well as bio-terrorism and chemical nerve agent blood toxins. The firm’s products include AdenoPlus, InflammaDry, FebriDx. The company was founded by Robert P. Sambursky and Robert W. VanDine in 2004 and is headquartered in Sarasota, FL.

Elanco Tiergesundheit AG manufactures animal vaccines. The firm provides pet health, livestock and Bioprotection products. The company's products include Atopica, Capstar, Deramaxx, Fortekor, Interceptor, Milbemax, Parc-tic and Sentinel. It is headquartered in Basel, Switzerland.

PHARMAQ AS operates as a veterinary pharmaceutical company. It provides health products to the global aquaculture industry. The company was founded on July 23, 2004 and is headquartered in Overhalla, Norway.

Riverside Partners LLC (Riverside Partners) is a private equity firm founded in 1989. The firm is headquartered in Boston, Massachusetts.

MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium.

OPKO Diagnostics LLC engages in the provision of health services. It develops blood testing devices for use in homes and doctors offices. The company was founded by Vincent Linder, George M. Whitesides, David Steinmiller, and Samuel K. Sia in 2004 and is headquartered in Woburn, MA.

Progression Therapeutics, Inc. develops prognostic tests and therapies for the treatment of cancer. Its products are used in the treatment of primary and metastatic cancer. The firm develops a tumor suppressor gene product that has demonstrated potent anti-tumor activity both in vitro and in vivo. The company was founded on December 27, 2001 and is headquartered in Houston, TX.

Pharmaq Holding AS invests in shares, obligations, real properties, and other participations. The company was founded on February 22, 2013 and is headquartered in Overhalla, Norway.

Popper & Co. LLC is a strategy consulting and transaction advisory firm. It serves the medical technology and life sciences industries. The company was founded by Caroline Popper and Kenneth G. Walz on June 1, 2003 and is headquartered in Baltimore, MD.

RareCyte Inc. develops life science research and diagnostic that focuses on characterizing and isolating rare cells in the blood. It engages in bringing its technology to the life sciences research, drug development and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. It's ground-breaking sccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells and circulating endothelial cells from whole blood. The company was founded by Ronald Seubert in 2009 and is headquartered in Seattle, WA.

Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London.

Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia.

AX Enterprize LLC specializes in hardware, software and systems engineering and light electro-mechanical manufacturing. It also designs and develops hardware components and cable harnesses (copper and fiber) for airborne, land vehicle assets and terrestrial installations. The company is headquartered in Yorkville, NY.

BioAgilytix Labs LLC engages in the provision of specialized bioanalytical testing laboratory. It offers gene therapy, biosimilars, antibody drug conjugates and immuno-oncology solutions. The company was founded by Afshin Safavi in 2008 and is headquartered in Durham, NC.

StepStoneMed, Inc. develops software which acquires and retain clinical knowledge and recall patient care protocols. Its software is used by the physicians, nurses, medical students, aides and volunteers. The company was founded by David Eagleman and Matthew Timberlake in 2009 and is headquartered in Houston, TX.

Nuritas Ltd. provides bioinformatics technology services. It offers products for human health and nutrition, cosmetics and personal care, animal health and nutrition. The firm’s disruptive approach to discovery combines artificial intelligence and DNA analysis to data-mine billions of molecules. The company was founded by Nora Khaldi and is headquartered in Dublin, Ireland.

BALX Holdings LLC operates as a biotechnology firm which offers health care services. The company was incorporated in 2013 and is headquartered in Boston, MA.

Part of SC Group, Inc., Stonehaven Consulting AG is a Swiss company that provides life sciences management consulting services. The company is based in Frauenfeld, Switzerland. The company was founded in 2015 by George C. Gunn, Paddy Holahan. The CEO is Matthias Manuel Hofer.

ViroVet NV is a Belgian company that focuses on the discovery, licensing, and development of biopharmaceutical products for livestock. The company is based in Leuven, Belgium. ViroVet was founded by Erwin Blomsma, Stefaan Wera, and Nesya Goris, with Erwin Blomsma serving as the CEO since incorporation.

Anizome LLC is a private company based in Houston. The American company provides a description of their services in non-English text, which appears to be related to online sports betting and casino games.

Stonehaven Incubate AG provides investment services in animal health sector. The company is headquartered in Andermatt, Switzerland.

Part of Healius Ltd., Agilex Biolabs Pty Ltd. is a bioanalytical and toxicology laboratory based in Thebarton, Australia. The Australian company has been in the industry for 25 years and is known for delivering bioanalytical services for nonclinical and clinical trials with international research standards. Agilex has accelerated hundreds of trials worldwide with reliable and defendable toxicology studies, clinical bioanalysis, and biomarker data to improve human health. Jason Valentine has been the CEO of the company since 2019. Agilex Biolabs was acquired by Healius Ltd. on February 01, 2022 for $216.62 million.

Avance Clinical Pty Ltd. is a premium full-service CRO that delivers quality clinical trials for international biotechs. Avance Clinical is based in Thebarton, AU, and has subsidiaries in the United States. The Australian company provides fast, agile, and adaptive solution-oriented clinical research services to biotechs in their drug development phases. The CEO of the company is Yvonne Lungershausen.

Mabvista, Inc. is a biotechnology firm that specializes in producing monoclonal antibodies. The company is based in Houston, TX.